Ontology type: schema:ScholarlyArticle
2019-07-08
AUTHORSR Sakai, K Ohmachi, F Sano, R Watanabe, H Takahashi, H Takasaki, M Tanaka, Y Hattori, H Kimura, M Takimoto, T Tachibana, E Tanaka, Y Ishii, Y Ishiyama, M Hagihara, K Miyazaki, K Yamamoto, N Tomita, K Ando
ABSTRACTThe optimal dose, schedule, and other aspects of bendamustine plus rituximab treatment remain unclear for patients with relapsed or refractory follicular lymphoma (FL). Herein, we analyzed the efficacy of bendamustine combined with rituximab (RB-120) treatment for Japanese patients with relapsed or refractory FL. This phase II clinical trial included patients with relapsed or refractory FL who received 375 mg/m2 rituximab on day 1 and 120 mg/m2 bendamustine on days 2 and 3 every 28 days for up to 6 cycles. The primary endpoint was the overall response rate (ORR), and the secondary endpoints included the complete response (CR) rate, progression-free survival (PFS), overall survival (OS), and safety. Thirty-seven patients were enrolled in the trial (median age 62 years, range 42–75 years). All patients were previously treated with rituximab-containing chemotherapy, and 83.8% were previously treated with the R-CHOP regimen. A median of 5 cycles (range 1–6) and 48.6% of patients completed 6 cycles. The ORR was 91.9% (95% confidence interval [CI] 78.1–98.3%), with a CR rate of 86.5% (95% CI 71.2–95.5%). The 3-year PFS and OS were 70.9% (95% CI 52.3–83.3%) and 88.9% (95% CI 73.1–95.7%), respectively, with the median 39.5 months follow-up duration. The most-frequently observed grade 3/4 adverse events were hematologic: lymphopenia (95%) and neutropenia (70%). No treatment-related deaths were observed. RB-120 showed a good efficacy with equivalent toxicities, compared with the bendamustine 120 mg/m2 monotherapy. However, the problem of high drop-out incidences cannot be ignored. More... »
PAGES2131-2138
http://scigraph.springernature.com/pub.10.1007/s00277-019-03750-7
DOIhttp://dx.doi.org/10.1007/s00277-019-03750-7
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1117831570
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/31286196
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Oncology and Carcinogenesis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Adult",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Antineoplastic Combined Chemotherapy Protocols",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Bendamustine Hydrochloride",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Disease-Free Survival",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Female",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Follow-Up Studies",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Lymphoma, Follicular",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Male",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Middle Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Neutropenia",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Rituximab",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Survival Rate",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Department of Medical Oncology, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-ku, 241-0815, Yokohama, Japan",
"id": "http://www.grid.ac/institutes/grid.414944.8",
"name": [
"Department of Medical Oncology, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-ku, 241-0815, Yokohama, Japan"
],
"type": "Organization"
},
"familyName": "Sakai",
"givenName": "R",
"id": "sg:person.01300452360.13",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01300452360.13"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Division of Hematology/Oncology, Tokai University School of Medicine, Isehara, Japan",
"id": "http://www.grid.ac/institutes/grid.265061.6",
"name": [
"Division of Hematology/Oncology, Tokai University School of Medicine, Isehara, Japan"
],
"type": "Organization"
},
"familyName": "Ohmachi",
"givenName": "K",
"id": "sg:person.01321520521.34",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01321520521.34"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Hematology, Yokohama City Seibu Hospital, St. Marianna University School of Medicine, Yokohama, Japan",
"id": "http://www.grid.ac/institutes/grid.417363.4",
"name": [
"Department of Hematology, Yokohama City Seibu Hospital, St. Marianna University School of Medicine, Yokohama, Japan"
],
"type": "Organization"
},
"familyName": "Sano",
"givenName": "F",
"id": "sg:person.01314144575.00",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01314144575.00"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Medical Oncology, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-ku, 241-0815, Yokohama, Japan",
"id": "http://www.grid.ac/institutes/grid.414944.8",
"name": [
"Department of Medical Oncology, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-ku, 241-0815, Yokohama, Japan"
],
"type": "Organization"
},
"familyName": "Watanabe",
"givenName": "R",
"id": "sg:person.012637131732.19",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012637131732.19"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japan",
"id": "http://www.grid.ac/institutes/grid.268441.d",
"name": [
"Department of Medical Oncology, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-ku, 241-0815, Yokohama, Japan",
"Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japan"
],
"type": "Organization"
},
"familyName": "Takahashi",
"givenName": "H",
"id": "sg:person.0711631331.23",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0711631331.23"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Medical Oncology, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-ku, 241-0815, Yokohama, Japan",
"id": "http://www.grid.ac/institutes/grid.414944.8",
"name": [
"Department of Medical Oncology, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-ku, 241-0815, Yokohama, Japan"
],
"type": "Organization"
},
"familyName": "Takasaki",
"givenName": "H",
"id": "sg:person.0774122402.27",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0774122402.27"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan",
"id": "http://www.grid.ac/institutes/grid.413045.7",
"name": [
"Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan"
],
"type": "Organization"
},
"familyName": "Tanaka",
"givenName": "M",
"id": "sg:person.01171141246.33",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171141246.33"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japan",
"id": "http://www.grid.ac/institutes/grid.268441.d",
"name": [
"Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japan"
],
"type": "Organization"
},
"familyName": "Hattori",
"givenName": "Y",
"id": "sg:person.01015062766.23",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01015062766.23"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Hematology, Kitasato University School of Medicine, Sagamihara, Japan",
"id": "http://www.grid.ac/institutes/grid.410786.c",
"name": [
"Department of Hematology, Kitasato University School of Medicine, Sagamihara, Japan"
],
"type": "Organization"
},
"familyName": "Kimura",
"givenName": "H",
"id": "sg:person.016265736132.51",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016265736132.51"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Hematology, Yokohama City Seibu Hospital, St. Marianna University School of Medicine, Yokohama, Japan",
"id": "http://www.grid.ac/institutes/grid.417363.4",
"name": [
"Department of Hematology, Yokohama City Seibu Hospital, St. Marianna University School of Medicine, Yokohama, Japan"
],
"type": "Organization"
},
"familyName": "Takimoto",
"givenName": "M",
"id": "sg:person.015432173733.59",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015432173733.59"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan",
"id": "http://www.grid.ac/institutes/grid.413045.7",
"name": [
"Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan"
],
"type": "Organization"
},
"familyName": "Tachibana",
"givenName": "T",
"id": "sg:person.01074653417.74",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01074653417.74"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Division of Hematology, Shounan Kamakura General Hospital, Kamakura, Japan",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Division of Hematology, Shounan Kamakura General Hospital, Kamakura, Japan"
],
"type": "Organization"
},
"familyName": "Tanaka",
"givenName": "E",
"id": "sg:person.015432307121.34",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015432307121.34"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japan",
"id": "http://www.grid.ac/institutes/grid.268441.d",
"name": [
"Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japan"
],
"type": "Organization"
},
"familyName": "Ishii",
"givenName": "Y",
"id": "sg:person.0665120613.58",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0665120613.58"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japan",
"id": "http://www.grid.ac/institutes/grid.268441.d",
"name": [
"Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japan"
],
"type": "Organization"
},
"familyName": "Ishiyama",
"givenName": "Y",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japan",
"id": "http://www.grid.ac/institutes/grid.268441.d",
"name": [
"Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japan"
],
"type": "Organization"
},
"familyName": "Hagihara",
"givenName": "M",
"id": "sg:person.0663130331.38",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663130331.38"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Transfusion and Cell Transplantation, Kitasato University School of Medicine, Sagamihara, Japan",
"id": "http://www.grid.ac/institutes/grid.410786.c",
"name": [
"Department of Transfusion and Cell Transplantation, Kitasato University School of Medicine, Sagamihara, Japan"
],
"type": "Organization"
},
"familyName": "Miyazaki",
"givenName": "K",
"id": "sg:person.013672700062.32",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013672700062.32"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Hematology, Yokohama City Minato Red Cross Hospital, Yokohama, Japan",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Department of Hematology, Yokohama City Minato Red Cross Hospital, Yokohama, Japan"
],
"type": "Organization"
},
"familyName": "Yamamoto",
"givenName": "K",
"id": "sg:person.013260042324.47",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013260042324.47"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japan",
"id": "http://www.grid.ac/institutes/grid.268441.d",
"name": [
"Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japan"
],
"type": "Organization"
},
"familyName": "Tomita",
"givenName": "N",
"id": "sg:person.01155656464.01",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01155656464.01"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Division of Hematology/Oncology, Tokai University School of Medicine, Isehara, Japan",
"id": "http://www.grid.ac/institutes/grid.265061.6",
"name": [
"Division of Hematology/Oncology, Tokai University School of Medicine, Isehara, Japan"
],
"type": "Organization"
},
"familyName": "Ando",
"givenName": "K",
"id": "sg:person.015274442102.98",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015274442102.98"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1007/s12185-016-2146-4",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1053131460",
"https://doi.org/10.1007/s12185-016-2146-4"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/bmt.2012.244",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1028358194",
"https://doi.org/10.1038/bmt.2012.244"
],
"type": "CreativeWork"
}
],
"datePublished": "2019-07-08",
"datePublishedReg": "2019-07-08",
"description": "The optimal dose, schedule, and other aspects of bendamustine plus rituximab treatment remain unclear for patients with relapsed or refractory follicular lymphoma (FL). Herein, we analyzed the efficacy of bendamustine combined with rituximab (RB-120) treatment for Japanese patients with relapsed or refractory FL. This phase II clinical trial included patients with relapsed or refractory FL who received 375\u00a0mg/m2 rituximab on day 1 and 120\u00a0mg/m2 bendamustine on days 2 and 3 every 28\u00a0days for up to 6\u00a0cycles. The primary endpoint was the overall response rate (ORR), and the secondary endpoints included the complete response (CR) rate, progression-free survival (PFS), overall survival (OS), and safety. Thirty-seven patients were enrolled in the trial (median age 62\u00a0years, range 42\u201375\u00a0years). All patients were previously treated with rituximab-containing chemotherapy, and 83.8% were previously treated with the R-CHOP regimen. A median of 5\u00a0cycles (range 1\u20136) and 48.6% of patients completed 6\u00a0cycles. The ORR was 91.9% (95% confidence interval [CI] 78.1\u201398.3%), with a CR rate of 86.5% (95% CI 71.2\u201395.5%). The 3-year PFS and OS were 70.9% (95% CI 52.3\u201383.3%) and 88.9% (95% CI 73.1\u201395.7%), respectively, with the median 39.5\u00a0months follow-up duration. The most-frequently observed grade 3/4 adverse events were hematologic: lymphopenia (95%) and neutropenia (70%). No treatment-related deaths were observed. RB-120 showed a good efficacy with equivalent toxicities, compared with the bendamustine 120\u00a0mg/m2 monotherapy. However, the problem of high drop-out incidences cannot be ignored.",
"genre": "article",
"id": "sg:pub.10.1007/s00277-019-03750-7",
"inLanguage": "en",
"isAccessibleForFree": false,
"isPartOf": [
{
"id": "sg:journal.1358129",
"issn": [
"0939-5555",
"1432-0584"
],
"name": "Annals of Hematology",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "9",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "98"
}
],
"keywords": [
"refractory follicular lymphoma",
"progression-free survival",
"overall response rate",
"follicular lymphoma",
"overall survival",
"rituximab treatment",
"observed grade 3/4 adverse events",
"response rate",
"grade 3/4 adverse events",
"multicenter phase II study",
"phase II clinical trial",
"efficacy of bendamustine",
"complete response rate",
"rituximab-containing chemotherapy",
"treatment-related deaths",
"phase II study",
"R-CHOP regimen",
"primary endpoint",
"secondary endpoints",
"rituximab therapy",
"II study",
"adverse events",
"CR rate",
"Japanese patients",
"clinical trials",
"optimal dose",
"patients",
"day 1",
"day 2",
"better efficacy",
"bendamustine",
"RB 120",
"lymphoma",
"trials",
"endpoint",
"efficacy",
"survival",
"treatment",
"high drop",
"equivalent toxicity",
"rituximab",
"neutropenia",
"monotherapy",
"lymphopenia",
"regimen",
"chemotherapy",
"therapy",
"incidence",
"dose",
"months",
"median",
"death",
"rate",
"toxicity",
"duration",
"days",
"safety",
"schedule",
"study",
"events",
"cycle",
"Herein",
"aspects",
"drop",
"problem"
],
"name": "Bendamustine-120 plus rituximab therapy for relapsed or refractory follicular lymphoma: a multicenter phase II study",
"pagination": "2131-2138",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1117831570"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s00277-019-03750-7"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"31286196"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s00277-019-03750-7",
"https://app.dimensions.ai/details/publication/pub.1117831570"
],
"sdDataset": "articles",
"sdDatePublished": "2022-05-20T07:36",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_826.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1007/s00277-019-03750-7"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00277-019-03750-7'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00277-019-03750-7'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00277-019-03750-7'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00277-019-03750-7'
This table displays all metadata directly associated to this object as RDF triples.
339 TRIPLES
22 PREDICATES
107 URIs
97 LITERALS
21 BLANK NODES